Key facts
- This page summarizes Anthony Taparo's Form 4 filing for Surgery Partners, Inc. (SGRY).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 13 Mar 2024, 16:40.
Anthony Taparo - 11 Mar 2024 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)
- Reporting relationship
- Chief Growth Officer
- Issuer ticker
- SGRY
- Reported as of
- 11 Mar 2024
- Net transaction value
- -$42,738
- SEC form
- 4
- Accepted by SEC
- 13 Mar 2024, 16:40:32 UTC
- Prior SEC filing
- 06 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jennifer Baldock, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Anthony Taparo filed Form 4 for Surgery Partners, Inc. (SGRY) on 13 Mar 2024.
Change
- Previous filing in this sequence was filed on 06 Mar 2024.
- Current net transaction value: -$42,738.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SGRY
transaction
Common Stock
Sale
- Transaction value
- $19,231
- Shares
- -651
- Change %
- -0.63%
- Price
- $29.54
- Shares after
- 103,108
- Date
- 11 Mar 2024
- Ownership
- Direct
- Footnotes
- F1, F2
SGRY
transaction
Common Stock
Sale
- Transaction value
- $23,508
- Shares
- -787
- Change %
- -0.76%
- Price
- $29.87
- Shares after
- 102,321
- Date
- 12 Mar 2024
- Ownership
- Direct
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 10, 2024.
Footnote F2
The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Footnote F3
Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 11, 2024.